• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Injectable Hydrogel Delivering Stem Cell Nanovesicles Aids Spinal Cord Injury Models

by
November 7, 2026
in Biology
Reading Time: 3 mins read
0
Injectable Hydrogel Delivering Stem Cell Nanovesicles Aids Spinal Cord Injury Models

Injectable Hydrogel Delivering Stem Cell Nanovesicles Aids Spinal Cord Injury Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have developed an injectable reactive oxygen species-responsive nanoscaffold combined with mesenchymal stem cell-derived nanovesicles, designated RNS + NVs, for the treatment of spinal cord injury. In preclinical evaluations, the scaffold effectively scavenged and degraded reactive oxygen species while enabling the responsive release of nanovesicles to address severe inflammatory reactions and oxidative stress that exacerbate degenerative progression.

Although extracellular vesicles derived from mesenchymal stem cells are recognized for their capacity to alleviate inflammation following spinal cord injury, their natural yield is limited. To overcome this production constraint, researchers generated nanovesicles from mesenchymal stem cells using physical extrusion, obtaining substantially higher yields while preserving therapeutic activity.

In laboratory cell cultures, the extruded nanovesicles suppressed pro-inflammatory shifts and reduced the secretion of interleukin-6 and tumor necrosis factor-alpha from lipopolysaccharide-stimulated BV2 cells, matching the anti-inflammatory efficacy of natural extracellular vesicles. Furthermore, the nanovesicles demonstrated a more pronounced antioxidative effect than extracellular vesicles by mitigating oxidative stress damage in hydrogen peroxide-exposed PC12 cells.

In experimental spinal cord injury models, cellular uptake of the extruded nanovesicles was predominantly mediated by microglia and neurons. The combined RNS + NVs system exhibited synergistic actions by modulating the hostile local microenvironment during the acute post-injury phase.

By simultaneously controlling oxidative damage and acute neuroinflammation, the nanoscaffold and nanovesicle platform created a favorable setting for tissue healing, long-term locomotion recovery, and the alleviation of neuropathic pain, demonstrating strong potential as an antioxidant and anti-inflammatory intervention for spinal cord injury.

The study focuses directly on the dual pathophysiological barriers that characterize spinal cord injury: the surge in reactive oxygen species and the accompanying severe inflammatory reactions, both of which accelerate degenerative tissue breakdown. While conventional therapeutic exploration has utilized extracellular vesicles originating from mesenchymal stem cells to temper post-injury inflammation, low production yields have historically restricted their broader deployment. To resolve this limitation, the authors implemented physical extrusion of mesenchymal stem cells. This mechanical method yielded nanovesicles in quantities significantly higher than those achieved with naturally harvested extracellular vesicles, establishing an efficient manufacturing alternative while maintaining vital therapeutic capabilities.

The engineered nanovesicles were systematically integrated into a reactive oxygen species-responsive hydrogel nanoscaffold to create the combined RNS + NVs delivery system. In this formulation, the scaffold serves an active dual role rather than functioning as a passive carrier. It directly scavenges and degrades local reactive oxygen species, and this chemical scavenging process simultaneously triggers the responsive release of the encapsulated nanovesicles. By coupling biomaterial degradation directly to oxidative stress levels, the platform ensures that the therapeutic nanovesicles are discharged in response to the hostile microenvironmental conditions that drive spinal cord pathology.

In vitro cellular investigations detailed in the research demonstrated specific cellular responses across distinct neural cell models. In lipopolysaccharide-stimulated BV2 microglial cells, the extruded nanovesicles successfully suppressed pro-inflammatory alterations and decreased the secretion of interleukin-6 and tumor necrosis factor-alpha, achieving an anti-inflammatory efficacy comparable to that of natural mesenchymal stem cell extracellular vesicles. In oxidative stress assays utilizing hydrogen peroxide-treated PC12 neuronal cells, the nanovesicles provided a more pronounced antioxidative protective effect than standard extracellular vesicles, significantly attenuating cell damage caused by oxidative exposure.

Within experimental spinal cord injury models, cellular tracking revealed that the therapeutic uptake of extruded nanovesicles was predominantly carried out by microglia and neurons. The combination of the responsive scaffold and extruded nanovesicles operated synergistically to alter the damaging in vivo microenvironment during the critical acute post-injury phase. This modulation subdued acute neuroinflammation and oxidative damage, establishing favorable conditions for endogenous tissue healing, significant long-term locomotor recovery, and the alleviation of neuropathic pain in the evaluated animal models.

Published in BMC Biotechnology as accepted, peer-reviewed research, these findings define the baseline therapeutic potential of the RNS + NVs biomaterial platform under controlled laboratory conditions. The reported outcomes reflect observations derived strictly from cultured cell lines and preclinical animal injury models. Because human physiological responses to acute spinal cord trauma involve complex systemic factors not fully captured in experimental models, further translational evaluations remain necessary to determine whether these antioxidant, anti-inflammatory, and neuroprotective effects can be replicated in clinical therapeutic settings.

Subject of Research: Injectable ROS-responsive hydrogel delivering mesenchymal stem cell nanovesicles for spinal cord injury

Article Title: Regenerative therapy using MSCs-derived reinforced extracellular vesicles incorporated into ROS-responsive injectable hydrogel for the treatment of spinal cord injury

Article References: Guan, J., Chen, X., Cheng, J., Lu, Y., & Chen, X. (2026). Regenerative therapy using MSCs-derived reinforced extracellular vesicles incorporated into ROS-responsive injectable hydrogel for the treatment of spinal cord injury. BMC Biotechnology. https://doi.org/10.1186/s12896-026-01206-1

Image Credits: AI Generated

DOI: 10.1186/s12896-026-01206-1

Keywords: spinal cord injury, mesenchymal stem cells, nanovesicles, extracellular vesicles, hydrogel, reactive oxygen species, neuroinflammation, tissue healing, Regenerative, therapy, MSCs-derived, reinforced

News Source: Cassandra Pierce. (November 7, 2026). Injectable Hydrogel Delivering Stem Cell Nanovesicles Aids Spinal Cord Injury Models. Scienmag.

Tags: extracellular vesicleshydrogelmesenchymal stem cellsMSCs-derivedNanovesiclesNeuroinflammationreactive oxygen speciesregenerativereinforcedSpinal Cord Injurytherapytissue healing
Share12Tweet7Share2ShareShareShare1

Related Posts

Mammalian Herbivores Exhibit Evolutionary Adaptations Resisting Mammary Cancer Development

Mammalian Herbivores Exhibit Evolutionary Adaptations Resisting Mammary Cancer Development

November 20, 2026
Chitrakoot Ethnobotanical Survey Documents 119 Medicinal Plants Across Indigenous and Saint Communities

Chitrakoot Ethnobotanical Survey Documents 119 Medicinal Plants Across Indigenous and Saint Communities

November 20, 2026

Ancient tRNA-Binding Module Safeguards Translation Fidelity in Human Alanyl-tRNA Synthetase

November 20, 2026

Specialized Phages Shift Wastewater Plasmids Without Altering Broader Bacterial Communities

November 20, 2026

POPULAR NEWS

  • Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    29 shares
    Share 12 Tweet 7
  • Acidic Ponds Link to Lower Pathogen Prevalence in Palmate Newts

    29 shares
    Share 12 Tweet 7
  • Early YAP and Beta-Catenin Signaling Links Stomach Infection to Liver Colonization

    29 shares
    Share 12 Tweet 7
  • Cold Storage Preserves Peach Firmness by Triggering RNA Degradation of Expansin Transcripts

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Bibliometric Study Maps Rapid Growth and Geographic Concentration in AI Traditional Medicine

Mammalian Herbivores Exhibit Evolutionary Adaptations Resisting Mammary Cancer Development

Only 8.4 Percent of Men Perform Monthly Testicular Self-Examinations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.